Physician profile
Bryan Demyan
NPI 1376032680
$1,595.65
in general payments reported to CMS, 2019-2025
10 companies · $25.10 in 2025
The $25.10 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2022: $145 · 2023: $184 · 2024: $1,040 · 2025: $25.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,249.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $477.30 | 2023-2024 | |
| Stryker Corporation | $312.91 | 2024 | T2 Alpha, Gamma, Axsos |
| Invictus Surgical Incorporated | $251.62 | 2024 | |
| Davol INC. | $145.08 | 2022 | |
| Becton, Dickinson and Company | $140.95 | 2019 | |
| Kerecis Limited | $126.44 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Rock Medical Orthopedics, INC. | $60.37 | 2019 | |
| Zimmer Biomet Holdings, INC. | $35.38 | 2024 | A.L.P.S., Affixus |
| Skeletal Dynamics INC | $25.10 | 2025 | Align, Geminus, Ijs |
| Cdc Medical LLC | $20.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Demyan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.